Stay updated on SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-01T01:34:14.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A sitewide banner announces an NIH website transition and says that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T01:32:17.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:12:22.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T01:49:48.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now displayed when accessing the study record NCT03238027, replacing the usual content. This indicates an access restriction or server-side issue preventing viewing the study details.
    Difference
    23%
    Check dated 2026-09-20T00:41:49.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6 in the page footer. This indicates a minor version update with no evident changes to the study details presented on the page.
    Difference
    0.0%
    Check dated 2026-08-29T19:32:22.000Z thumbnail image

Stay in the know with updates to SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.